» Articles » PMID: 32400358

Estimating Number of Cases and Spread of Coronavirus Disease (COVID-19) Using Critical Care Admissions, United Kingdom, February to March 2020

Overview
Journal Euro Surveill
Date 2020 May 14
PMID 32400358
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

An exponential growth model was fitted to critical care admissions from two surveillance databases to determine likely coronavirus disease (COVID-19) case numbers, critical care admissions and epidemic growth in the United Kingdom before the national lockdown. We estimate, on 23 March, a median of 114,000 (95% credible interval (CrI): 78,000-173,000) new cases and 258 (95% CrI: 220-319) new critical care reports, with 527,000 (95% CrI: 362,000-797,000) cumulative cases since 16 February.

Citing Articles

Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.

Kucharski A, Chung K, Aubry M, Teiti I, Teissier A, Richard V PLoS Med. 2023; 20(9):e1004283.

PMID: 37683046 PMC: 10516411. DOI: 10.1371/journal.pmed.1004283.


Perception of Saudi Population about COVID-19: A Cross-Sectional Study.

Mahfouz M, AlQahtani B Int J Prev Med. 2023; 14:6.

PMID: 36942036 PMC: 10023845. DOI: 10.4103/ijpvm.IJPVM_649_20.


Optimal non-pharmaceutical pandemic response strategies depend critically on time horizons and costs.

Nowak S, Nascimento de Lima P, Vardavas R Sci Rep. 2023; 13(1):2416.

PMID: 36765151 PMC: 9912209. DOI: 10.1038/s41598-023-28936-y.


Cluster Analysis of US COVID-19 Infected States for Vaccine Distribution.

Shih D, Shih P, Wu T, Li C, Shih M Healthcare (Basel). 2022; 10(7).

PMID: 35885762 PMC: 9323689. DOI: 10.3390/healthcare10071235.


Estimating the effects of lockdown timing on COVID-19 cases and deaths in England: A counterfactual modelling study.

Arnold K, Gilthorpe M, Alwan N, Heppenstall A, Tomova G, Mckee M PLoS One. 2022; 17(4):e0263432.

PMID: 35421094 PMC: 9009677. DOI: 10.1371/journal.pone.0263432.


References
1.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

2.
Verity R, Okell L, Dorigatti I, Winskill P, Whittaker C, Imai N . Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20(6):669-677. PMC: 7158570. DOI: 10.1016/S1473-3099(20)30243-7. View

3.
Nishiura H, Linton N, Akhmetzhanov A . Serial interval of novel coronavirus (COVID-19) infections. Int J Infect Dis. 2020; 93:284-286. PMC: 7128842. DOI: 10.1016/j.ijid.2020.02.060. View

4.
. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(12):343-346. PMC: 7725513. DOI: 10.15585/mmwr.mm6912e2. View

5.
Mizumoto K, Kagaya K, Zarebski A, Chowell G . Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020; 25(10). PMC: 7078829. DOI: 10.2807/1560-7917.ES.2020.25.10.2000180. View